جست‌وجوی استاد و پژوهشگر

Thomas Diekwischمشاهده پروفایل

استاد

• Craniofacial Development
• Epigenetics
• Periodontal Biology
• +۴ مورد دیگر

Thomas Diekwisch is a tenured Professor and Head of the Department of Oral and Craniofacial Sciences at the University of Rochester School of Medicine and Dentistry. He holds the Margaret and Cy Welcher Professorship in Dental Research and directs the Center for Oral and Craniofacial Sciences. Previously, he served at institutions like the University of Illinois and Texas A&M, holding roles such as Allan G. Brodie Endowed Chair. His research integrates developmental biology, epigenetics, and biomaterials engineering to advance understanding of tooth and periodontal tissue formation. Diekwisch earned dual PhDs in Anatomy and Philosophy of Science from Philipps-University of Marburg, alongside a DMD in Dentistry. His work spans 119+ peer-reviewed articles, focusing on enamel biomineralization, chromatin dynamics, and regenerative therapies. Key contributions include elucidating epigenetic mechanisms in periodontal differentiation and developing biomimetic scaffolds for tissue regeneration. His lab investigates SFRP1’s role in periodontal ligament homeostasis and explores YAP/TAZ signaling in mineralized tissue maintenance. Research interests include: Epigenetic regulation of odontogenic lineages Wnt pathway modulation in periodontal health/disease Biomaterials for craniofacial repair Evolutionary tooth morphology

Pinar Zorlutunaمشاهده پروفایل

استاد

• Bioengineering
• Tissue Engineering
• Regenerative Medicine
• +۱۲ مورد دیگر

Pinar Zorlutuna is the Roth-Gibson Professor of Bioengineering and Director of the Bioengineering Graduate Program at the University of Notre Dame, within the College of Engineering and the Department of Chemical and Biomolecular Engineering. She leads a dynamic research lab focused on bio-inspired systems for disease modeling and regenerative medicine. Research Interests: Her work centers on tissue engineering, genetic engineering, and micro/nanotechnology to create biomimetic models of human tissues. Key areas include aging, cancer (particularly breast), and cardiovascular disease. Her lab investigates cell-cell and cell-matrix interactions, with emphasis on extracellular vesicles, the cardiac microenvironment, and 3D bioprinting. The recent publications highlight a strong trend toward modeling age-related disease progression, especially in cardiac and breast tissue. Many studies explore how aging alters the extracellular matrix and vesicle cargo, influencing disease outcomes and drug responses. Another major theme is bio-inspired computing, with research on cardiac muscle cell-based networks for biocomputing and memory systems. Elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows National Academy of Sciences Kavli Fellow Roth-Gibson Professor of Bioengineering Member, NIH CSR Cellular and Molecular Technologies Study Section NSF CAREER Award NSF EFRI BEGIN Award Dr. Zorlutuna advises graduate students and leads major federally funded grants focused on aging heart models and cardiac biocomputing. Her lab, the Zorlutuna Lab, develops innovative tools such as 3D bioprinted tissue models, microfluidic devices, and bio-oscillatory networks. Future work includes advancing real-time diagnostic platforms, personalized tissue models, and implantable biocomputational systems.

• Stem Cell Research
• Periodontal Regeneration
• Tissue Engineering
• +۳ مورد دیگر

Associate Professor Danijela Menicanin holds the position of Associate Dean, Student Experience in the Medical Sciences division at the University of Adelaide. Her research focuses on stem cell biology, with particular emphasis on mesenchymal stem cells derived from dental tissues and placenta, exploring their applications in regenerative medicine. Key areas of interest include periodontal ligament regeneration, osteoarthritis pathogenesis, and cell differentiation mechanisms. Her work investigates the molecular regulation of stem cell lineages, such as the role of Hes4 and Twist-1 transcription factors in bone marrow stromal cells, as well as the impact of signaling molecules like Semaphorin 3A on mesenchymal stem cell properties. She has contributed to developing methodologies for generating neural crest-like cells from induced pluripotent stem cells and assessing ectopic bone formation potential in placental-derived stem cells. Recent studies (2023) examine the role of Grem1-lineage progenitor cells in osteoarthritis, revealing critical pathways for cartilage maintenance. Her research also addresses educational strategies, such as flipped learning approaches for health sciences educators. While no specific awards are listed, her extensive publication record reflects significant contributions to stem cell biology and translational medicine. Dr. Menicanin's work bridges basic research and clinical applications, with a focus on optimizing stem cell-based therapies for periodontal and musculoskeletal disorders. Her current role in student experience oversight demonstrates dual expertise in academic leadership and scientific innovation.

Nagarajan Kannanمشاهده پروفایل

استادیار

• Stem Cell Biology
• Cancer Biology
• Breast Cancer
• +۱۵ مورد دیگر

Nagarajan Kannan, Ph.D., is an Assistant Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic, Rochester, Minnesota. He holds an administrative appointment as Senior Associate Consultant I-Research in both the Division of Experimental Pathology and Laboratory Medicine and the Department of Cancer Biology. Dr. Kannan leads the Stem Cell and Cancer Biology Laboratory, where he integrates single-cell technologies, genetic clonal tracking, and functional assays to investigate the origins of breast cancer in epithelial stem and progenitor cells. Ph.D. in Molecular Medicine, University of Auckland Postdoctoral Fellowships in Stem Cell Biology, University of British Columbia and Terry Fox Laboratory M.Sc. in Industrial Biotechnology, Bharathiar University B.Sc. in Biochemistry, The American College Dr. Kannan's research focuses on the molecular mechanisms underlying cancer initiation, particularly in aging mammary stem and progenitor cells. His work explores lineage-specific tumor suppression, oxidative signaling in therapy resistance, and the role of clonal evolution in metastasis. His lab aims to identify pre-malignant cells in healthy tissues to enable early detection and preventive therapies for high-risk individuals. His recent publications highlight advancements in clonal tracking, single-cell proteomics, and organoid modeling, with applications in breast, ovarian, lung, and salivary gland cancers. These studies reflect a strong emphasis on translational research, integrating mass spectrometry, DNA barcoding, and functional genomics. Editorial Board Member, Reactive Oxygen Species , 2015–2018 Chair, Canadian Association of Postdoctoral Scholars, 2014–2015 Recipient, Mitacs Elevate Postdoctoral Award, 2013–2015 Recipient, Canadian Breast Cancer Foundation Postdoctoral Fellowship, 2011–2013 Multiple Scholar-in-Training Awards from AACR and other societies Dr. Kannan actively mentors trainees, serves on national grant review panels (NIH, DoD, NHMRC), and collaborates across disciplines to advance regenerative cancer medicine. His lab contributes to the Mayo Clinic Comprehensive Cancer Center and the Center for Regenerative Biotherapeutics, emphasizing interdisciplinary innovation in cancer biology.

Zong Weiمشاهده پروفایل

دانشیار

• Epigenetics
• Diabetes
• Metabolism
• +۶ مورد دیگر

Zong Wei, Ph.D., is an Associate Professor of Physiology at Mayo Clinic , where he leads the Epigenomics of Metabolic Diseases Laboratory . His research focuses on understanding the epigenetic and transcriptional mechanisms underlying diabetes, obesity, and inflammation, using advanced tools like genetic mouse models , human organoid systems , and single-cell multi-omics to identify therapeutic targets. Key research areas include: Mechanistic studies of hormone-induced epigenetic switches in pancreatic beta cell function Discovery of novel chromatin modulators in metabolic diseases via CRISPR screening Elucidating epigenetic crosstalk between pancreatic islets and their microenvironment Investigating SWI/SNF complexes in glucocorticoid signaling Developing next-generation multi-omic platforms for tissue heterogeneity analysis His recent publications highlight advancements in enhancer region analysis , Vitamin D's role in diabetes , and BRD9-mediated interferon signaling . Dr. Wei has received grants from prestigious programs, including the NIDDK K01 Award and Beckman Coulter SPRI Grant , and was a finalist for the American Diabetes Association’s Initiator Award .

Joao Passosمشاهده پروفایل

استاد

• Cellular Senescence
• Aging Mechanisms
• Mitochondrial Dysfunction
• +۳ مورد دیگر

Joao Passos, Ph.D., is a Professor of Physiology at Mayo Clinic, holding dual appointments in the Department of Physiology & Biomedical Engineering and the Section of Geriatric Medicine and Gerontology. His research focuses on cellular senescence mechanisms, particularly mitochondrial dysfunction and telomere damage in aging and age-related diseases. He investigates how senescent cells contribute to age-related pathologies and develops therapies targeting these processes to extend healthspan. Education: PhD in Molecular Biology from Newcastle University and MSc in Biology from University of Porto. Research Interests: Senescence biomarkers, telomere dysfunction dynamics, mitochondrial regulation of senescence, and translational strategies to mitigate senescence-driven diseases. His lab uses super-resolution microscopy and reporter systems to study telomere damage, while exploring mitochondrial ROS production and SASP regulation. Publications: Recent work includes SenNet guidelines for senescence detection, mitochondrial roles in SASP, and senescence in skeletal muscle aging. His research bridges basic biology with clinical applications in anti-aging therapies.

Anna Huttenlocherمشاهده پروفایل

استاد

• Immunology
• Cell Migration
• Inflammation
• +۱۴ مورد دیگر

Anna Huttenlocher is a Professor in the Department of Medical Microbiology & Immunology and Pediatrics at the University of Wisconsin–Madison, School of Medicine and Public Health. She leads an active research laboratory focused on cell migration, inflammation, and tissue repair, using zebrafish and human iPSC models. Research Interests: Her research centers on the molecular mechanisms regulating leukocyte migration, particularly neutrophils and macrophages, during inflammation, wound healing, and cancer. She investigates how reactive oxygen species (ROS), calcium signaling, and cytoskeletal dynamics control cell motility and tissue regeneration. Her lab also studies host-pathogen interactions, particularly with Aspergillus fumigatus and Candida auris , and how immune responses influence tumor progression. Using advanced live imaging, microfluidics, and organotypic models, her work bridges basic cell biology and translational immunology. Publication Trends: Her recent publications reflect a strong focus on in vivo imaging of immune cell dynamics, redox signaling in wound repair, neutrophil motility regulation, and host-pathogen interactions. There is a clear trend toward integrating human iPSC-derived models with zebrafish systems to study conserved mechanisms of inflammation and immunity. Scientific Awards: 2017: American Society of Cell Biology Fellow for Lifetime Achievement 2015: Elected to National Academy of Medicine 2011: UW-Madison WARF Kellett Mid-Career Awardee 2009: Elected to American Pediatric Society 2007: Burroughs Wellcome Foundation Clinical Scientist Award 2007: UW-Madison WARF Romnes Faculty Fellow 2005: Member, American Society of Clinical Investigation 2005: American Heart Association McClain Research Award 2001: Gerard B. Odell Award for Pediatric Research 2000: Shaw Scientist Award (Greater Milwaukee Foundation) Advising and Grants: Dr. Huttenlocher mentors numerous students and postdoctoral fellows, many of whom have secured independent fellowships (e.g., F31, F32) and faculty positions. Her lab has received funding from NIH, NSF, and institutional sources, supporting interdisciplinary collaborations with labs such as Beebe (microfluidics), Slukvin (iPSC), and Eliceiri (imaging). She fosters a collaborative, rigorous, and inclusive research environment. Labs and Teams: The Huttenlocher Lab is known for its innovative use of zebrafish for real-time imaging of inflammation and wound healing. The lab collaborates extensively with LOCI (Laboratory for Optical and Computational Instrumentation), the Beebe Lab (microfluidics), and the Slukvin Lab (iPSC-derived immune cells), forming a multidisciplinary team to address complex questions in immunology and cell biology.

Oliver Kretzمشاهده پروفایل

پژوهشگر

• Kidney Aging
• Podocyte Biology
• Interorgan Signaling
• +۳ مورد دیگر

Oliver Kretz, PD.Dr.med., is a researcher at the University Medical Center Hamburg-Eppendorf (UKE), affiliated with the III. Department of Medicine. He leads the Laboratory for Structural Biology of the Kidney , focusing on kidney aging, podocyte biology, and interorgan communication using advanced techniques like transmission electron microscopy and single-nuclei transcriptomics. His work leverages models including mice, zebrafish, and Drosophila to study DNA repair deficiencies and ultrastructural alterations in kidney disease. Research interests span kidney aging mechanisms , podocyte dynamics , and mitochondrial dysfunction in neurodegeneration. Key themes include metabolic regulation, immune-mediated podocytopathies, and mitochondrial DNA damage in Parkinson's-like pathology. His lab emphasizes the role of interorgan signaling in systemic aging. Kretz's publications predominantly explore kidney filtration barriers , autoimmune nephropathies , and molecular imaging . Recent work reveals trends in targeting mitochondrial metabolism, proteostasis in glomerular cells, and nanoscale pathology profiling. Collaborative studies highlight podocyte injury mechanisms and immune-microbiome interactions. He co-leads initiatives like the Hamburg Center of Neuroscience (HCNS) and contributes to international consortia (e.g., ISGD). No awards or advised students are documented in the provided texts.

Caroline Burnsمشاهده پروفایل

عضو هیئت علمی

• Cardiovascular Development
• Heart Regeneration
• Zebrafish Models
• +۷ مورد دیگر

Caroline Burns is a research scientist in the Cardiology Research unit at Boston Children's Hospital, affiliated with Harvard Medical School’s Faculty of Medicine. Her work focuses on the molecular and genetic mechanisms underlying heart development and regeneration, primarily using zebrafish as a model organism. Her research interests span cardiovascular development , heart regeneration , zebrafish models , molecular genetics , and regenerative medicine . She investigates key processes such as cardiomyocyte proliferation, splicing regulation, epigenetic control, and signaling pathways (e.g., Notch, Wnt, TGFß) during cardiac morphogenesis and repair. Her work integrates advanced techniques including transcriptomics, gene editing, and deep learning-based phenotyping. The analysis of her recent publications reveals a strong trend in organ-wide transcriptomic mapping , genetic and epigenetic regulation of heart regeneration , and disease modeling of congenital heart defects . Her studies frequently explore how developmental pathways influence regenerative capacity, with implications for human cardiac therapies. Dr. Burns has not been publicly recognized with scientific awards in the provided text. However, her consistent publication record in high-impact journals underscores her scientific contributions. She has not listed any formal advisees or grant funding in the available information. Nonetheless, her leadership in generating complex genetic models and multi-omics datasets suggests active mentorship and research oversight within her team. Her research is conducted within the Cardiology Research unit at Boston Children's Hospital, a leading center for pediatric cardiovascular science. This environment supports cutting-edge investigations into heart development and regenerative mechanisms using zebrafish and other models.

Stephanie K. Douganمشاهده پروفایل

دانشیار

• Cancer Immunology
• Immunotherapy
• Pancreatic Cancer
• +۷ مورد دیگر

Stephanie K. Dougan is an Investigator at the Dana-Farber Cancer Institute and holds dual faculty positions at Harvard Medical School as Associate Professor of Immunology and Assistant Professor of Microbiology. Her research focuses on overcoming immunotherapy resistance in pancreatic cancer through innovative mouse models and immunological strategies. Dr. Dougan received her PhD in Immunology from Harvard University, where she studied lipid antigen presentation and NKT cell development with Richard Blumberg. She then completed a postdoctoral fellowship with Hidde Ploegh at the Whitehead Institute, specializing in somatic cell nuclear transfer and CRISPR genome editing for mouse model development. Her research interests center on the immune microenvironment of pancreatic cancer, particularly why these tumors resist T cell infiltration and immunotherapy. The Dougan Lab investigates strategies to manipulate the tumor immune landscape, focusing on cytokine therapy, checkpoint blockade, and IAP antagonists to enhance anti-tumor immunity. Using transnuclear and CRISPR-modified mice, her team probes the determinants of immune response in densely fibrotic tumors. The 15 most recent publications highlight a strong focus on pancreatic cancer immunology, T cell activation, cytokine signaling, and therapeutic resistance. Key themes include the role of IFNγ in immune equilibrium, CDK4/6 inhibition in T cell memory, TGF-β blockade in chemotherapy response, and mechanisms of immune-related adverse events. Her work frequently appears in top-tier journals such as Cell , Nature , and Science Translational Medicine . GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation (2019) Broadening the impact of immunotherapy to pancreatic cancer: Challenges and opportunities (2019) Regulation of innate and adaptive antitumor immunity by IAP antagonists (2018) Unmasking Pancreatic Cancer: Epitope Spreading After Single Antigen Chimeric Antigen Receptor T-Cell Therapy in a Human Phase I Trial (2018) Dr. Dougan is actively involved in education and mentorship, serving as course director for the Harvard Immunology Summer Undergraduate Program, co-director for the graduate course Immunology 201, and course director for an Advanced Integrated Science course for medical students. Her lab collaborates extensively with the Hale Family Center for Pancreatic Cancer Research to profile tumor microenvironments and test targeted therapies. She has secured significant research grants supporting her work on pancreatic cancer immunology and has mentored numerous students and postdoctoral researchers who appear as co-authors on her publications. The Dougan Lab at Dana-Farber Cancer Institute is dedicated to translating basic immunological discoveries into novel cancer therapies, particularly for treatment-resistant cancers like pancreatic adenocarcinoma. The lab employs a multidisciplinary approach combining genetic engineering, immunology, and preclinical modeling to identify new therapeutic targets and combination strategies.

Carolina Hagbergمشاهده پروفایل

پژوهشگر

• Lipid Metabolism
• Adipose Tissue Biology
• Cardiometabolic Diseases
• +۵ مورد دیگر

Carolina Hagberg is a Principal Researcher and Docent at the Karolinska Institutet , leading her research group at the Department of Medicine, Solna. Her work integrates vascular biology with nutrient biochemistry to study lipid handling in health and cardiometabolic disease, particularly focusing on adipose tissue dysfunction during obesity. PhD in Cell and Molecular Biology (2011) at Karolinska Institutet M.Sc. in Biochemistry (2006) at University of Helsinki Her research combines human biopsies , organotypic models like HUVAS, and in vivo animal studies to explore pathways linking obesity to type 2 diabetes and atherosclerosis. Key themes include: Adipose tissue microvasculature and lipid uptake Metabolic targeting of adipocyte dysfunction Species differences in adipose biology Role of perivascular fat in cardiovascular disease Recent publications highlight advancements in 3D adipocyte models , lactate regulation , and ECM remodeling in obesity. Scientific awards include: Best Swedish pre-clinical doctoral thesis in diabetes (2011) Best M.Sc. thesis in Biochemistry (2006) VR Starting Grant (2019) Diabetes Wellness Foundation Grant (2023) As a dedicated mentor, she supervises PhD students and postdocs while co-leading collaborative networks. The lab operates at BioClinicum, Stockholm, within the Centre for Molecular Medicine and Strategic Research Programme in Diabetes .

Qiaolin Dengمشاهده پروفایل

دانشیار

• Cell and Molecular Biology
• Developmental Biology
• Endocrinology and Diabetes
• +۲ مورد دیگر

Qiaolin Deng is an Associate Professor and Principal Researcher at the Department of Physiology and Pharmacology, Karolinska Institutet, Sweden. Her research group focuses on germ cell biology and developmental programming in epigenetic inheritance of diseases, particularly addressing how maternal health conditions like polycystic ovary syndrome (PCOS) and diabetes impact offspring health through placental and germline mechanisms. Her research integrates mouse disease models, human stem cell cultures (including induced pluripotent stem cells and placental organoids), single-cell sequencing (Smart-seq2, LCM-seq), and microfluidic co-culture systems to investigate molecular pathways in developmental programming. Key themes include epigenetic remodeling, X-chromosome dosage effects, and modeling of maternal disease signatures in offspring. Recent publications highlight her work on PCOS transgenerational effects, placental gene regulation, diabetes-related germline modifications, and advanced single-cell methodologies. She has secured prestigious grants including the Wallenberg Academy Fellow Grant, VR Consolidator Grant, and KIRI Fellow Grant, reflecting significant recognition in developmental biology and metabolic-reproductive medicine. Scientific Awards: KI Research Incubator (KIRI) Fellow postdoc grant (2022) Wallenberg Academy Fellow Grant (2019) Karolinska Institutet Consolidator Grant Swedish Research Council (VR) Consolidator Grant Young Investigator grants from Swedish Society for Medical Research, Swedish Medical Research Council, and KI Central Faculty Fund Her lab has trained numerous researchers, including PhD and master’s students, and collaborates with institutions such as UT Southwestern Medical Center, Tongji University, and Medical University of Vienna. Teaching contributions include EMBO courses on single-cell omics and advanced physiology lectures at Karolinska and Royal Institute of Technology.

Staffan Strömbladمشاهده پروفایل

استاد

• Cancer Cell Biology
• Cell-Matrix Interactions
• Mechanotransduction
• +۴ مورد دیگر

Staffan Strömblad is a Professor at Karolinska Institutet in the Department of Medicine, Huddinge, where he leads the Cell Biology of Cancer research group. He also serves as Scientific Director of the Live Cell Imaging Core Facility and is a Member of the Nobel Assembly. His research focuses on how extracellular matrix (ECM) interactions influence cancer progression, cellular migration, and mechanotransduction signaling pathways. Research Interests: Strömblad investigates ECM stiffness-induced oncogenic transformation, Rho GTPase-regulated cell migration dynamics, PAK4 kinase in senescence bypass, and breast cancer metastasis. His work integrates live-cell imaging, molecular biology, and biomechanical analyses to uncover mechanisms driving tumor aggressiveness. Publication Trends: Recent articles emphasize ECM biomechanics, PAK4 signaling in cancer, high-content migration imaging, and transcriptional reprogramming during tumor progression. Key themes include mechanotransduction, senescence escape, and metastasis. Advising & Funding: He mentors PhD students (e.g., Christos Vogiatzakis, Feifei Yan) and secures grants from the Swedish Research Council, Swedish Cancer Society, and Worldwide Cancer Research. His lab uses advanced microscopy to study real-time cell dynamics. Infrastructure: As director of the Live Cell Imaging Facility, he oversees cutting-edge microscopy resources for BSL1/BSL2 cellular and tissue imaging, supporting quantitative analyses of cell behavior.

• Mitochondrial Metabolism
• Cellular Metabolism
• Cancer Biology
• +۳ مورد دیگر

Jessica Brooke Spinelli is an Assistant Professor at the UMass Chan Medical School within the Program in Molecular Medicine . She holds multiple affiliations across Morningside Graduate School of Biomedical Sciences departments including Biochemistry and Molecular Biotechnology, Cancer Biology, and Translational Science. BSc in Biochemistry from Hofstra University PhD in Chemical Biology from Harvard University Her research focuses on mitochondrial metabolism and its role in cellular decision-making. Key areas include: Metabolic reprogramming in obesity and cancer Redox homeostasis and stress survival Electron transport chain dynamics Lipid-metabolism interactions Thermogenesis in adipose tissues Metabolic vulnerabilities in disease states Recent publications (2023-2025) highlight her work on: Rhodoquinone's role in mammalian electron transport Sex-specific metabolic enzyme phosphorylation in obesity MCJ/DnaJC15's influence on brown fat thermogenesis Glucose-pyrimidine interdependencies in cancer Ammonia recycling mechanisms in tumor growth Selenium-ubiquinone interactions in ferroptosis She collaborates extensively with researchers in: Molecular Medicine Biochemistry Cancer Biology Metabolic Disease

• Biochemistry
• Molecular Biology
• Mitochondrial Metabolism
• +۶ مورد دیگر

Jorge Sastre Serra is a Full Professor in the Department of Biochemistry and Molecular Biology within the Department of Fundamental Biology and Health Sciences at the University of the Balearic Islands (UIB). He has been serving in this role since April 2022, following prior appointments as Interim Contracted Doctor Professor (2019–2022), Assistant Professor Doctor (2018–2019), and Associate Professor (2015–2018). He is also the Secretary of the department and a member of the Multidisciplinary Group of Translational Oncology (GMOT) at IUNICS and IdISBa. Degree in Biology, University of the Balearic Islands (2007) Degree in Biochemistry, University of the Balearic Islands (2007) PhD in Biochemistry and Molecular Biology, University of the Balearic Islands (2012) His research focuses on mitochondrial metabolism and oxidative stress in cancer , particularly examining the role of estrogen receptors in mitochondrial dynamics, biogenesis, and their implications in oncogenesis. His work spans molecular mechanisms of redox balance, metabolic reprogramming in tumors, and translational applications for cancer therapy. The most recent publications reflect a strong focus on mitochondrial biology in cancer, with recurring themes including mitochondrial fission/fusion, estrogen receptor signaling, oxidative stress pathways, and their integration into translational oncology. Articles emphasize both mechanistic insights and clinical relevance, demonstrating a consistent trajectory toward understanding cancer metabolism and identifying novel therapeutic targets. 2 teaching quinquennia recognized 2 research sexennia (2007–2015 and 2016–2021) Remuneration supplements for teaching excellence and permanent training Remuneration supplements for research activity and excellence Remuneration supplements for knowledge transfer Jorge Sastre Serra has participated in 29 national and local research projects, serving as Principal Investigator in 6 of them. He also acts as co-Investigator in 4 fundraising projects coordinated by FUEIB or IdISBa, highlighting his active engagement in securing research funding and collaborative science. He teaches in both undergraduate (Biochemistry, Molecular Biology) and postgraduate (Biomedical Research Master’s) programs and supervises Master's and Bachelor's theses, as well as doctoral students in Translational Research and Food Sciences programs. His primary research is conducted within the Multidisciplinary Group of Translational Oncology (GMOT) , a consolidated R&D group affiliated with IUNICS and IdISBa, which fosters interdisciplinary collaboration between basic scientists and clinicians to advance cancer research from bench to bedside.